Procept BioRobotics (PRCT) reported a Q1 net loss Thursday of $0.45 per diluted share, narrowing from a loss of $0.51 a year earlier.

Analysts polled by FactSet expected a loss of $0.49.

Revenue for the quarter ended March 31 was $69.2 million, up from $44.5 million a year earlier.

Analysts surveyed by FactSet expected $65.4 million.

For 2025, the surgical robotics company lifted its revenue guidance to $323 million from the previous $320 million. Analysts polled by FactSet expect $322 million.

Shares of the company were up more than 2% in recent premarket activity.